000 | 01465 a2200445 4500 | ||
---|---|---|---|
005 | 20250518015826.0 | ||
264 | 0 | _c20191129 | |
008 | 201911s 0 0 eng d | ||
022 | _a1545-5017 | ||
024 | 7 |
_a10.1002/pbc.27571 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDilly-Feldis, Marie | |
245 | 0 | 0 |
_aExpression of PD-1/PD-L1 in children's classical Hodgkin lymphomas. _h[electronic resource] |
260 |
_bPediatric blood & cancer _c05 2019 |
||
300 |
_ae27571 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
650 | 0 | 4 |
_aB7-H1 Antigen _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xmetabolism |
650 | 0 | 4 | _aRemission Induction |
700 | 1 | _aAladjidi, Nathalie | |
700 | 1 | _aRefait, John K | |
700 | 1 | _aParrens, Marie | |
700 | 1 | _aDucassou, Stéphane | |
700 | 1 | _aRullier, Anne | |
773 | 0 |
_tPediatric blood & cancer _gvol. 66 _gno. 5 _gp. e27571 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.27571 _zAvailable from publisher's website |
999 |
_c29249043 _d29249043 |